Haemonetics Corporation
HAE
Classifica tra le azioni
#3263
Haemonetics Corporation is a healthcare enterprise dedicated to providing... Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, operations, and supply chains. The Blood Center division provides advanced automated blood component and manual whole blood collection technologies. This includes MCS brand apheresis equipment for selectively collecting blood components, as well as disposable kits for whole blood collection and storage. Its software offerings feature the SafeTrace Tx blood bank information system and BloodTrack, a sophisticated suite of blood management software and hardware designed to enhance hospital blood bank functionalities and facilitate bedside transfusions. For the Hospital sector, Haemonetics offers hemostasis analyzer systems like TEG, ClotPro, and HAS, which deliver crucial assessments of a patient's overall clotting ability. The TEG Manager software links these analyzers throughout a facility, enabling clinicians to remotely access active and past test results to inform treatment decisions. Additionally, the Cell Saver Elite+ system supports autologous blood recovery across a wide range of surgical procedures, including cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological operations. The company distributes its products and solutions through its own direct sales teams, independent distributors, and sales representatives. Haemonetics Corporation was established in 1971 and is based in Boston, Massachusetts.
Prezzo delle azioni
$118.50
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$5.39B
Variazione (1 giorno)
0.01%
Variazione (1 anno)
133.68%
Paese
US
Scambia Haemonetics Corporation (HAE)
Categoria
Healthcare
Numero di azioni in circolazione per Haemonetics Corporation (HAE)
Numero di azioni in circolazione al June 2026: 45.36M
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Haemonetics Corporation, il numero attuale di azioni in circolazione è 45.36M. Alla fine del March 2024, la società aveva 50.71M azioni in circolazione. Il numero di azioni in circolazione è solitamente influenzato da split azionari e riacquisti.
Storico delle azioni in circolazione di Haemonetics Corporation (HAE) dal 2000 al 2026
Azioni in circolazione alla fine di ogni anno
| Anno | Azioni in circolazione | Cambia |
|---|---|---|
| 2026 (TTM) | 45.36M | -9.87% |
| 2025 | 50.33M | -0.74% |
| 2024 | 50.71M | -0.15% |
| 2023 | 50.78M | -0.52% |
| 2022 | 51.05M | 0.71% |
| 2021 | 50.69M | -0.01% |
| 2020 | 50.69M | -1.63% |
| 2019 | 51.53M | -2.32% |
| 2018 | 52.76M | 2.43% |
| 2017 | 51.51M | 1.17% |
| 2016 | 50.91M | -1.21% |
| 2015 | 51.53M | -0.15% |
| 2014 | 51.61M | 0.51% |
| 2013 | 51.35M | 1.22% |
| 2012 | 50.73M | 1.14% |
| 2011 | 50.15M | -1.47% |
| 2010 | 50.90M | 0.24% |
| 2009 | 50.78M | -1.68% |
| 2008 | 51.65M | -3.45% |
| 2007 | 53.49M | 1.01% |
| 2006 | 52.96M | 3.74% |
| 2005 | 51.05M | 4.45% |
| 2004 | 48.87M | -0.63% |
| 2003 | 49.18M | -6.19% |
| 2002 | 52.43M | 3.62% |
| 2001 | 50.60M | -3.02% |
| 2000 | 52.17M | 0.00% |
Azioni in circolazione per aziende simili o concorrenti
| Azienda | Azioni in circolazione | Differenza | Il paese |
|---|---|---|---|
| 1.74B | 3,742.62% |
US
|
|
| 1.28B | 2,726.44% |
IE
|
|
| 383.50M | 745.44% |
US
|
|
| 1.48B | 3,157.42% |
US
|
|
| - | - |
DE
|
